These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 34788328)

  • 41. Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.
    Lee DH; Heidecke H; Schröder A; Paul F; Wachter R; Hoffmann R; Ellrichmann G; Dragun D; Waschbisch A; Stegbauer J; Klotz P; Gold R; Dechend R; Müller DN; Saft C; Linker RA
    Mol Neurodegener; 2014 Nov; 9():49. PubMed ID: 25398321
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin II receptor agonist antibodies are associated with microvascular damage in lupus nephritis.
    Mejia-Vilet JM; López-Hernández YJ; Santander-Vélez JI; Trujeque-Matos M; Cruz C; Carranza de la Torre CA; Espinosa-Cruz V; Espinosa-González R; Uribe-Uribe NO; Morales-Buenrostro LE
    Lupus; 2020 Apr; 29(4):371-378. PubMed ID: 32041505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic.
    Edlow AG; Li JZ; Collier AY; Atyeo C; James KE; Boatin AA; Gray KJ; Bordt EA; Shook LL; Yonker LM; Fasano A; Diouf K; Croul N; Devane S; Yockey LJ; Lima R; Shui J; Matute JD; Lerou PH; Akinwunmi BO; Schmidt A; Feldman J; Hauser BM; Caradonna TM; De la Flor D; D'Avino P; Regan J; Corry H; Coxen K; Fajnzylber J; Pepin D; Seaman MS; Barouch DH; Walker BD; Yu XG; Kaimal AJ; Roberts DJ; Alter G
    JAMA Netw Open; 2020 Dec; 3(12):e2030455. PubMed ID: 33351086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19.
    Cervia C; Nilsson J; Zurbuchen Y; Valaperti A; Schreiner J; Wolfensberger A; Raeber ME; Adamo S; Weigang S; Emmenegger M; Hasler S; Bosshard PP; De Cecco E; Bächli E; Rudiger A; Stüssi-Helbling M; Huber LC; Zinkernagel AS; Schaer DJ; Aguzzi A; Kochs G; Held U; Probst-Müller E; Rampini SK; Boyman O
    J Allergy Clin Immunol; 2021 Feb; 147(2):545-557.e9. PubMed ID: 33221383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiotensin II type 1 receptor antibodies and native kidney function in pediatric liver and intestinal transplant recipients.
    Stern R; Chen L; Chan AP; Wozniak LJ; Pearl M
    Pediatr Nephrol; 2023 Dec; 38(12):4175-4185. PubMed ID: 37432534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoimmune mechanisms activating the angiotensin AT1 receptor in 'primary' aldosteronism.
    Kem DC; Li H; Velarde-Miranda C; Liles C; Vanderlinde-Wood M; Galloway A; Khan M; Zillner C; Benbrook A; Rao V; Gomez-Sanchez CE; Cunningham MW; Yu X
    J Clin Endocrinol Metab; 2014 May; 99(5):1790-7. PubMed ID: 24552217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiotensin II Type-1 Receptor Antibodies Are Associated With Active Allograft Dysfunction Following Pediatric Liver Transplantation.
    Wozniak LJ; Hickey MJ; Chan AP; Venick RS; Farmer DG; Busuttil RW; Reed EF; McDiarmid SV
    Transplantation; 2020 Dec; 104(12):2547-2556. PubMed ID: 32101982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accelerated rejection, thrombosis, and graft failure with angiotensin II type 1 receptor antibodies.
    Pearl MH; Leuchter RK; Reed EF; Zhang Q; Ettenger RB; Tsai EW
    Pediatr Nephrol; 2015 Aug; 30(8):1371-4. PubMed ID: 25956702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Repressed Ang 1-7 in COVID-19 Is Inversely Associated with Inflammation and Coagulation.
    Carpenter RM; Young MK; Petri WAO; Lyons GR; Gilchrist C; Carey RM; Petri WA
    mSphere; 2022 Aug; 7(4):e0022022. PubMed ID: 35913134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients.
    Günther J; Kill A; Becker MO; Heidecke H; Rademacher J; Siegert E; Radić M; Burmester GR; Dragun D; Riemekasten G
    Arthritis Res Ther; 2014 Mar; 16(2):R65. PubMed ID: 24612997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation.
    Pearl MH; Zhang Q; Palma Diaz MF; Grotts J; Rossetti M; Elashoff D; Gjertson DW; Weng P; Reed EF; Tsai Chambers E
    Kidney Int; 2018 Jan; 93(1):260-269. PubMed ID: 28927645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypertension, medications, and risk of severe COVID-19: A Massachusetts community-based observational study.
    Bauer AZ; Gore R; Sama SR; Rosiello R; Garber L; Sundaresan D; McDonald A; Arruda P; Kriebel D
    J Clin Hypertens (Greenwich); 2021 Jan; 23(1):21-27. PubMed ID: 33220171
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Specific COVID-19 Symptoms Correlate with High Antibody Levels against SARS-CoV-2.
    Amjadi MF; O'Connell SE; Armbrust T; Mergaert AM; Narpala SR; Halfmann PJ; Bashar SJ; Glover CR; Heffron AS; Taylor A; Flach B; O'Connor DH; Kawaoka Y; McDermott AB; Sethi AK; Shelef MA
    Immunohorizons; 2021 Jun; 5(6):466-476. PubMed ID: 34398806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
    Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C
    J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pre-transplant angiotensin receptor II type 1 antibodies and risk of post-transplant focal segmental glomerulosclerosis recurrence.
    Mujtaba MA; Sharfuddin AA; Book BL; Goggins WC; Khalil AA; Mishler DP; Fridell JA; Yaqub MS; Taber TE
    Clin Transplant; 2015 Jul; 29(7):606-11. PubMed ID: 25973696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin II type I receptor agonistic autoantibodies are associated with poor allograft survival in liver retransplantation.
    Xu Q; McAlister VC; Leckie S; House AA; Skaro A; Marotta P
    Am J Transplant; 2020 Jan; 20(1):282-288. PubMed ID: 31419065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ACE2 internalization induced by a SARS-CoV-2 recombinant protein is modulated by angiotensin II type 1 and bradykinin 2 receptors.
    Portales AE; Mustafá ER; McCarthy CI; Cornejo MP; Couto PM; Gironacci MM; Caramelo JJ; Perelló M; Raingo J
    Life Sci; 2022 Mar; 293():120284. PubMed ID: 35038454
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rejection and graft outcomes in kidney transplant recipients with and without angiotensin II receptor type 1 antibodies.
    Aljishi M; Isbel NM; Jegatheesan D; Johnson DW; Cho Y; Campbell SB; Hawley CM; Thornton A; Gillis D; Johnstone K
    Transpl Immunol; 2023 Feb; 76():101756. PubMed ID: 36460263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
    Lefaucheur C; Viglietti D; Bouatou Y; Philippe A; Pievani D; Aubert O; Duong Van Huyen JP; Taupin JL; Glotz D; Legendre C; Loupy A; Halloran PF; Dragun D
    Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vascular and Non-HLA autoantibody profiles in hospitalized patients with COVID-19.
    Lichtenstein B; Zheng Y; Gjertson D; Ferbas KG; Rimoin AW; Yang OO; Aldrovandi GM; Schaenman JM; Reed EF; Fulcher JA
    Front Immunol; 2023; 14():1197326. PubMed ID: 37398658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.